Literature DB >> 12096779

Call for revolution: a new approach to describing allograft deterioration.

Philip F Halloran.   

Abstract

I propose a set of definable entities in the renal transplant course, eliminating the need for the term 'chronic rejection'. The status of a renal transplant can be defined by the presence and extent of rejection (T-cell-mediated or antibody-mediated); allograft nephropathy (parenchymal atrophy, fibrosis, and fibrous intimal thickening in arteries); transplant glomerulopathy; specific diseases; and factors which could accelerate progression. The level of function and the slope of the loss of function should be separately determined. This approach can be applied both in research and in clinical practice, and can be adapted to other organ transplants.

Entities:  

Mesh:

Year:  2002        PMID: 12096779     DOI: 10.1034/j.1600-6143.2002.20301.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

Authors:  Yingyos Avihingsanon; Naili Ma; Martha Pavlakis; W James Chon; Marc E Uknis; Anthony P Monaco; Christiane Ferran; Isaac Stillman; Asher D Schachter; Christina Mottley; Xin Xiao Zheng; Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

Review 2.  IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.

Authors:  Robert S Gaston
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

3.  Contribution of Toll-like receptor activation to lung damage after donor brain death.

Authors:  Anthony J Rostron; David M W Cork; Vassilios S Avlonitis; Andrew J Fisher; John H Dark; John A Kirby
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

4.  Skin and kidney histological changes in graft-versus-host disease (GVHD) after kidney transplantation.

Authors:  Tadeja Pintar; Mario Alessiani; Alojz Pleskovič; Aleš Pleskovič; Ruda Zorc-Pleskovič; Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

5.  Chemokines and their receptors in human renal allotransplantation.

Authors:  Denise J Lo; Tim A Weaver; David E Kleiner; Roslyn B Mannon; Lynn M Jacobson; Bryan N Becker; S John Swanson; Douglas A Hale; Allan D Kirk
Journal:  Transplantation       Date:  2011-01-15       Impact factor: 4.939

6.  The Biology and Molecular Basis of Organ Transplant Rejection.

Authors:  Philip F Halloran; Gunilla Einecke; Majid L N Sikosana; Katelynn Madill-Thomsen
Journal:  Handb Exp Pharmacol       Date:  2022

Review 7.  Autophagy and liver ischemia-reperfusion injury.

Authors:  Raffaele Cursio; Pascal Colosetti; Jean Gugenheim
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

8.  Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection.

Authors:  Jian Shi; Fengbao Luo; Qianqian Shi; Xianlin Xu; Xiaozhou He; Ying Xia
Journal:  BMC Nephrol       Date:  2015-11-03       Impact factor: 2.388

Review 9.  Pharmacologic Complement Inhibition in Clinical Transplantation.

Authors:  Vasishta S Tatapudi; Robert A Montgomery
Journal:  Curr Transplant Rep       Date:  2017-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.